i was wrong to doubt......

*DJ Dr. Reddy's: Competition Likely To Be Limited As Fondaparinux A Complex Generic
Molecule

(MORE TO FOLLOW) Dow Jones Newswires
July 13, 2011 00:41 ET (04:41 GMT)
DJ Dr Reddy's Gets US OK To Sell Generic Injection To Prevent Blood Clots

BANGALORE (Dow Jones)--Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday it
has received final approval from the U.S. Food and Drug Administration to sell a generic
version of GlaxoSmithKline PLC's (GSK) Arixtra injection, which prevents blood clots
after surgery.
The approval is for 2.5 milligram per 0.5-milliliter, 5.0 mg per 0.4-ml, 7.5 mg per
0.6-ml and 10 mg per 0.8-ml doses of fondaparinux sodium in pre-filled, single-dose
syringes, the Indian generic drug maker said in a statement.
Dr. Reddy's will manufacture fondaparinux under license using a patented process
developed by Alchemia Ltd. (ACL.AU).